| Hans-Günter Meyer-Thompson | Verschiedene
Drug Early Warning from Re-Testing Biological Samples: Maryland Hospital Study
Drug Early Warning from Re-Testing Biological Samples: Maryland Hospital Study
Office of National Drug Control Policy, Executive Office of the President, July 2018